Nazal
NDC 49873-057, Naphazoline hydrochloride, liquid, from Sato Pharmaceutical Co., Ltd..
- Product NDC
- 49873-057
- Status
- Listed
- Labeler
- Sato Pharmaceutical Co., Ltd.
- Dosage form
- LIQUID
- Route
- NASAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49873-057 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPHAZOLINE HYDROCHLORIDE50 mg/100mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49873-057-01 | 49873005701 | 1 BOTTLE in 1 CARTON (49873-057-01) / 30 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 49873-057 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49873-057 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49873-057. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.